Verona Pharma Plc (VRNA) Annual Balance Sheets

Annual · GAAP · USD millions
Access VRNA quarterly Balance Sheets →
Reviewing balance sheet data across recent quarters allows users to assess how Verona Pharma Plc manages assets, liabilities, and equity through different cycles.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2024)
(Dec 31 2023) (Dec 31 2022) (Dec 31 2021) (Dec 31 2020)
Assets
Cash & cash equivalent399.76
Cash & Short-term Investments399.00
Accounts receivable31.50
Notes Receivable, Current0.00
Inventories6.25
Other Current Assets8.50
Prepaid Expense, Current AS7.57
Total Current Assets453.57
Equipment/Property/Plant Net1.11
Goodwill net0.55
Tax Assets, Noncurrent180.73
Other Assets, Noncurrent18.00
Tax Credit And Income Taxes Receivable Current5.76
Operating Lease Right Of Use Asset2.05
Total Assets474.24
Liabilities
Accounts Payable, Current AC11.27
Accrued Liabilities, Current AC6.18
Other Liabilities, Current5.77
Taxes Payable, Current, Total8.89
Total Current Liabilities42.68
Long-term debt120.34
Total Long-term Debt120.34
Accrued Income Taxes, Noncurrent82.21
Other liabilities, Noncurrent106.66
Operating Lease Liability Current1.12
Warrant Liability Current-
Operating Lease Liability Noncurrent1.24
Total Liabilities269.68
Stockholders' Equity
Common Stock Value45.02
Treasury Stock Value1.66
Additional Paid In Capital Common Stock728.20
Retained Earnings / Accumulated Deficit-562.40
Accumulated Other Comprehensive Income-4.60
Other Equity-4.60
Common Stockholder's Equity204.56
Total Stockholder's Equity204.56
Liabilities & Stockholder's Equity474.24
4 historic quarters locked

Sign in to unlock the full Verona Pharma Plc balance sheet history.

About Verona Pharma Plc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20241231)
  • Filed with the SEC: February 27, 2025
  • Source: vrna-20241231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001657312-25-000010

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License